Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy × abiraterone × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 35 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms, Castration-Resistant 2 Ovarian Neoplasms 2 Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer 2 Melanoma 2 Bulbo-Spinal Atrophy, X-Linked 2 Bites and Stings 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Salivary Gland Neoplasms 1 Prostate Adenocarcinoma 1 Primary Myelofibrosis 1 Pancreatic Neoplasms 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Hormone-Sensitive Prostate Cance 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡